[Retracted] Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma

Table 3

Univariate and multivariate analysis for PFS in localized patients.

Characteristics	PFS
	Univariate		Multivariate
	OR (95% CI)	value	OR (95% CI)	value
Age (≤65/>65)	0.99 (0.95–1.04)	0.676
Sex (male/female)	1.22 (0.33–4.60)	0.764
BMI (kg/m^2) (≤24/>24)	1.37 (0.36–5.19)	0.640
Hypertension (yes/no)	1.40 (0.38–5.20)	0.615
Family history (yes/no)	7.40 (0.61–90.15)	0.117
Symptom (yes/no)	10.67 (2.42–47.02)	0.002	10.67 (2.42–47.02)	0.002
Tumor size (cm)	1.46 (1.03–2.07)	0.034	2.04 (0.92–4.49)	0.079
Surgical procedure (PN/RN)	1.22 (0.27–5.38)	0.791
T classification (I/II)	1.06 (0.10–11.26)	0.961
Nuclear grade (1-2/3-4)	3.44 (0.89–13.19)	0.072
Necrosis (present/absent)	1.63 (0.14–19.81)	0.699
IL-35	1.02 (1.00–1.03)	0.012	1.02 (1.00–1.03)	0.011

PFS: progression-free survival, OR: odds ratio, CI: confidence interval, BMI: body mass index. PN: partial nephrectomy; RN: radical nephrectomy .